Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

Republic Healthcare Limited (8357.HK)

Compare
0.071
-0.001
(-1.39%)
At close: April 2 at 9:55:05 AM GMT+8
Loading Chart for 8357.HK
  • Previous Close 0.072
  • Open 0.072
  • Bid 0.064 x --
  • Ask 0.071 x --
  • Day's Range 0.072 - 0.072
  • 52 Week Range 0.051 - 0.160
  • Volume 85,000
  • Avg. Volume 54,508
  • Market Cap (intraday) 44.304M
  • Beta (5Y Monthly) 0.21
  • PE Ratio (TTM) --
  • EPS (TTM) -0.000
  • Earnings Date Mar 21, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Republic Healthcare Limited, an investment holding company, operates medical clinics in Singapore. It offers consultation, medical investigation, and treatment services; and men and women's sexual health services. The company provides its services through DTAP brand. It is also involved in management consultancy services; online and wholesale trade of goods; wholesale of medical, professional, scientific, and precision equipment; and educational support services. Republic Healthcare Limited was founded in 2010 and is headquartered in Singapore.

republichealthcare.asia

34

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 8357.HK

View More

Performance Overview: 8357.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

8357.HK
12.70%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

8357.HK
25.26%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

8357.HK
69.13%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

8357.HK
78.48%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 8357.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8357.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    44.30M

  • Enterprise Value

    44.30M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.88

  • Price/Book (mrq)

    0.61

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.93%

  • Return on Assets (ttm)

    -1.60%

  • Return on Equity (ttm)

    -1.41%

  • Revenue (ttm)

    9.23M

  • Net Income Avi to Common (ttm)

    -178.16k

  • Diluted EPS (ttm)

    -0.000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.52M

  • Total Debt/Equity (mrq)

    6.84%

  • Levered Free Cash Flow (ttm)

    -334.67k

Research Analysis: 8357.HK

View More

Company Insights: 8357.HK

Research Reports: 8357.HK

View More

People Also Watch